Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenograftsMi Sun Park(National Cancer Center), Seung Bae Rho(National Cancer Center)OncotargetJune 6, 201410.18632/oncotarget.2063Cited by 70SaveCiteExport RISWatch citationsRelated PapersSuppression of VEGF expression through interruption of the HIF-1α and Akt signaling cascade modulates the anti-angiogenic activity of DAPK in ovarian carcinoma cells|Oncology Reports|2013|19